Q-CROC Trademark

Trademark Overview


On Monday, January 12, 2015, a trademark application was filed for Q-CROC with the United States Patent and Trademark Office. The USPTO has given the Q-CROC trademark a serial number of 86501039. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 6, 2023. This trademark is owned by Consortium de recherche en oncologie cli nique du Québec. The Q-CROC trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Conducting seminars in the field of oncology; Conducting workshops and seminars in the field of clinical trials and research; Educational services, namely, providing classes, seminars and workshops in the fields of oncology and clinical trials and research; educational services, namely, organizing seminars, panel discussions for working and research groups, and conferences, in the field of human cancer; organization of educational forums for cancer research

Clinical trial management services, namely, providing clinical administrative and office support services for organizations and researchers in the field of oncology research in the nature of clearing house for information about clinical trials between industry and clinical community, promoting awareness of clinical trials and necessity of funding for such trials, creating a commercial directory of available resources for healthcare organization, compilation and management of clinical trial updates, providing advisory services and preparation of budgets, development and collection of data and performance metrics for business purposes

Medical and scientific research in the field of oncology; Medical research services in the field of human cancer; Medical and scientific research, namely, consulting on clinical trials; Providing medical and scientific research information in the area of human cancer; medical and scientific research in the field of therapeutic resistance to cancer, namely, conceiving, developing and managing biopsy-driven studies with biomarker discovery/validation, creating unique banks of biospecimens with platforms, identifying biomarkers of therapeutic resistance, providing expertise on translational projects, facilitating collaborations between basic scientists, clinical teams and the industry professionals
q-croc

General Information


Serial Number86501039
Word MarkQ-CROC
Filing DateMonday, January 12, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 6, 2023
Registration Number5163786
Registration DateTuesday, March 21, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2017

Trademark Statements


Goods and ServicesConducting seminars in the field of oncology; Conducting workshops and seminars in the field of clinical trials and research; Educational services, namely, providing classes, seminars and workshops in the fields of oncology and clinical trials and research; educational services, namely, organizing seminars, panel discussions for working and research groups, and conferences, in the field of human cancer; organization of educational forums for cancer research
Goods and ServicesClinical trial management services, namely, providing clinical administrative and office support services for organizations and researchers in the field of oncology research in the nature of clearing house for information about clinical trials between industry and clinical community, promoting awareness of clinical trials and necessity of funding for such trials, creating a commercial directory of available resources for healthcare organization, compilation and management of clinical trial updates, providing advisory services and preparation of budgets, development and collection of data and performance metrics for business purposes
Goods and ServicesMedical and scientific research in the field of oncology; Medical research services in the field of human cancer; Medical and scientific research, namely, consulting on clinical trials; Providing medical and scientific research information in the area of human cancer; medical and scientific research in the field of therapeutic resistance to cancer, namely, conceiving, developing and managing biopsy-driven studies with biomarker discovery/validation, creating unique banks of biospecimens with platforms, identifying biomarkers of therapeutic resistance, providing expertise on translational projects, facilitating collaborations between basic scientists, clinical teams and the industry professionals

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 6, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 6, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 6, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameConsortium de recherche en oncologie cli nique du Québec
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressQuébec (Québec) G1V0B9
CA

Party NameConsortium de recherche en oncologie cli nique du Québec
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressQuébec (Québec) G1V0B9
CA

Party NameConsortium de recherche en oncologie cli nique du Québec
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressQuébec (Québec) G1V0B9
CA

Trademark Events


Event DateEvent Description
Friday, October 6, 2023CANCELLED SEC. 8 (6-YR)
Wednesday, August 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 4, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 4, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 4, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, May 4, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, May 4, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 4, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 4, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 21, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 21, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, January 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 29, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 26, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 26, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 11, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, May 11, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, May 11, 2016INQUIRY TO SUSPENSION E-MAILED
Wednesday, May 11, 2016SUSPENSION INQUIRY WRITTEN
Wednesday, May 11, 2016SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, November 4, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 4, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, November 4, 2015SUSPENSION LETTER WRITTEN
Tuesday, November 3, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 3, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 23, 2015ASSIGNED TO LIE
Monday, October 5, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 21, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 21, 2015NON-FINAL ACTION E-MAILED
Tuesday, April 21, 2015NON-FINAL ACTION WRITTEN
Thursday, April 16, 2015ASSIGNED TO EXAMINER
Thursday, January 22, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 15, 2015NEW APPLICATION ENTERED